Free Trial

Hellenic Dynamics (HELD) Competitors

Hellenic Dynamics logo
GBX 0.95
0.00 (0.00%)
(As of 11/1/2024)

HELD vs. N4P, HLN, HIK, HCM, INDV, AMYT, AGY, APH, ANCR, and BXP

Should you be buying Hellenic Dynamics stock or one of its competitors? The main competitors of Hellenic Dynamics include N4 Pharma (N4P), Haleon (HLN), Hikma Pharmaceuticals (HIK), HUTCHMED (HCM), Indivior (INDV), Amryt Pharma (AMYT), Allergy Therapeutics (AGY), Alliance Pharma (APH), Animalcare Group (ANCR), and Beximco Pharmaceuticals (BXP). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Hellenic Dynamics vs.

Hellenic Dynamics (LON:HELD) and N4 Pharma (LON:N4P) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations, valuation and community ranking.

Hellenic Dynamics' return on equity of 0.00% beat N4 Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Hellenic DynamicsN/A N/A N/A
N4 Pharma N/A -82.39%-56.00%

In the previous week, N4 Pharma's average media sentiment score of 0.00 beat Hellenic Dynamics' score of -0.99 indicating that N4 Pharma is being referred to more favorably in the news media.

Company Overall Sentiment
Hellenic Dynamics Negative
N4 Pharma Neutral

Hellenic Dynamics has higher earnings, but lower revenue than N4 Pharma.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hellenic DynamicsN/AN/AN/AN/AN/A
N4 Pharma£23.52K121.67-£1.08MN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hellenic Dynamics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
N4 Pharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

0.1% of Hellenic Dynamics shares are held by institutional investors. 72.9% of Hellenic Dynamics shares are held by insiders. Comparatively, 18.0% of N4 Pharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

N4 Pharma received 103 more outperform votes than Hellenic Dynamics when rated by MarketBeat users.

CompanyUnderperformOutperform
Hellenic DynamicsN/AN/A
N4 PharmaOutperform Votes
103
65.61%
Underperform Votes
54
34.39%

Summary

Hellenic Dynamics beats N4 Pharma on 4 of the 7 factors compared between the two stocks.

Get Hellenic Dynamics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HELD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HELD vs. The Competition

MetricHellenic DynamicsDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£1.40M£1.13B£5.09B£1.42B
Dividend YieldN/A3.13%7.46%11.92%
P/E RatioN/A103.62133.021,596.48
Price / SalesN/A2,857.471,686.23220,893.99
Price / CashN/A10.0037.2227.13
Price / BookN/A3.214.622.91
Net IncomeN/A£141.80M£115.72M£157.91M
7 Day PerformanceN/A0.70%-0.59%0.78%
1 Month PerformanceN/A-1.05%5.80%-0.46%
1 Year PerformanceN/A96.78%34.16%116.45%

Hellenic Dynamics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HELD
Hellenic Dynamics
N/AGBX 0.95
flat
N/A+2,367.5%£1.40MN/A0.00N/ANews Coverage
N4P
N4 Pharma
N/AGBX 0.65
+8.3%
N/A-14.3%£2.57M£23,524.00-55.005Gap Down
High Trading Volume
HLN
Haleon
0.9128 of 5 stars
GBX 372.70
-0.5%
GBX 415
+11.3%
+16.0%£33.69B£11.26B3,105.8325,408High Trading Volume
HIK
Hikma Pharmaceuticals
2.5452 of 5 stars
GBX 1,903
-0.9%
GBX 2,325
+22.2%
+2.9%£4.22B£3.02B2,927.699,100
HCM
HUTCHMED
N/AGBX 291
-4.6%
N/A-10.3%£2.49B£610.81M-7,275.001,760Gap Down
High Trading Volume
INDV
Indivior
2.1044 of 5 stars
GBX 713.33
+2.4%
GBX 1,500
+110.3%
-55.1%£917.27M£1.15B-891.661,000Gap Down
AMYT
Amryt Pharma
N/AGBX 143
-11.7%
N/A+0.0%£457.11M£210.24M-4.33290Gap Down
AGY
Allergy Therapeutics
N/AGBX 5.28
-0.4%
N/A+279.3%£251.86M£53.26M-88.00612
APH
Alliance Pharma
2.6295 of 5 stars
GBX 46.20
+7.7%
GBX 60
+29.9%
+18.0%£249.74M£183.15M-770.0091,000High Trading Volume
ANCR
Animalcare Group
N/AGBX 232
+3.6%
N/A+36.2%£140.06M£76.10M2,900.00220High Trading Volume
BXP
Beximco Pharmaceuticals
N/AGBX 30.92
+1.4%
N/A-17.9%£137.95M£43.08B386.535,500

Related Companies and Tools


This page (LON:HELD) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners